NEW YORK, NY / ACCESSWIRE / January 8, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of NeoGenomics, Inc. ("NeoGenomics") (NASDAQ:NEO) concerning possible violations of federal securities laws.
On July 31, 2023, NeoGenomics' competitor, Natera, Inc., announced that it had sued NeoGenomics in federal court, alleging that the Company's cancer test, the RaDaR molecular residual disease assay, infringed Natera's patents. On December 27, 2023, Natera announced that the federal court had issued a preliminary injunction, effective immediately, barring NeoGenomics from making, using, selling, or promoting the RaDaR test, but that NeoGenomics may continue to offer RaDaR to existing patients and for clinical trials, studies, or projects already in process. The following day, NeoGenomics acknowledged the preliminary injunction, announcing that it would appeal the federal court's ruling. On this news, NeoGenomics' stock price fell $3.71 per share, or 18.1%, to close at $16.79 per share on December 28, 2023. To obtain additional information, go to:
https://zlk.com/pslra-1/neogenomics-lawsuit-submission-form-2?prid=62865&wire=1
or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212)363-7500.
WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212)363-7500
Fax: (212)363-7171
https://zlk.com/
SOURCE: Levi & Korsinsky, LLP
View the original
press release on accesswire.com
